Search
$50M Perot family gift expands UT Southwestern’s Medical Scientist Training Program: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/november-perot-family-gift.html
The Perot family, The Perot Foundation, and The Sarah and Ross Perot, Jr. Foundation have provided a transformative $50 million endowment for UT Southwestern’s Medical Scientist Training Program (MSTP), among the nation’s elite programs that provide graduates a dual M.D./Ph.D. degree to strengthen the advancement of laboratory discoveries into the clinical arena.
Chen, Hooper elected to National Academy of Medicine: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-national-academy-of-medicine.html
The National Academy of Medicine announced the election of two UT Southwestern Medical Center faculty members – Lora Hooper, Ph.D., Chair of Immunology, and Zhijian “James” Chen, Ph.D., Professor of Molecular Biology and Director of the Center for Inflammation Research.
Treating depression of parents boosts treatment of children’s asthma, study finds: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-treating-depression-of-parents.html
Depression and anxiety in the parents of children with asthma have been associated with increased clinic visits and asthma-related hospitalizations.
Use of racially concordant educational video did not affect acceptance of heart implant devices among Black patients : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/march-heart-implant-devices.html
Multiple studies have demonstrated that Black patients are significantly less likely than white patients to undergo invasive cardiovascular procedures. Prior research also has demonstrated substantial racial disparities in the use of implantable cardioverter-defibrillators (ICDs) that can be lifesaving for those at high risk for sudden cardiac death.
Mortality rates are higher in U.S. counties with more evictions, UTSW researchers find: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/december-mortality-rates-are-higher.html
Mortality rates are higher in U.S. counties where eviction rates are also elevated, and this trend is strongest in areas with higher proportions of Black residents and women, UT Southwestern researchers found.
UTSW ear experts recommend exams before buying OTC hearing aids: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-otc-hearing-aids.html
Adults with mild to moderate hearing loss who are considering buying hearing aids when they become available over the counter (OTC) later this month should first be examined by an audiologist and physician to determine if the devices will help them, UT Southwestern hearing specialists suggest.
Preventing “identity theft” in prostate cancer cells re-sensitizes them to therapy: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-prostate-cancer-cells.html
UTSW study suggests combination therapy might help prostate cancer patients overcome resistance to current treatments.
Cellular ‘waste product’ rejuvenates cancer-fighting immune cells : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/september-cellular-waste-product.html
A new study by UT Southwestern’s Simmons Cancer Center scientists suggests that lactate, a metabolic byproduct produced by cells during strenuous exercise, can rejuvenate immune cells that fight cancer.
UT Southwestern study highlights racial bias factors in physician assistant training: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-racial-bias-factors.html
Physician assistant (PA) programs need to actively engage Black/African American students to help address issues of systemic racism, according to a new study.
Breast cancer drug benefits broader group of patients, trial shows: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-breast-cancer-drug.html
A drug approved to treat breast cancer patients with mutations in the BRCA1 or BRCA2 genes may also benefit people who have other genetic mutations.